SPOTLIGHT: Regulus gets CEO


Alnylam Pharmaceuticals and Isis Pharmaceuticals have named Kleanthis G. Xanthopoulos as president and chief executive of their joint venture--Regulus Therapeutics. Xanthopoulos is the former CEO of Anadys. Release